These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8100090)
1. CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells. Monach PA; Schreiber H; Rowley DA Transplantation; 1993 Jun; 55(6):1356-61. PubMed ID: 8100090 [TBL] [Abstract][Full Text] [Related]
2. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758 [TBL] [Abstract][Full Text] [Related]
3. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection. Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467 [TBL] [Abstract][Full Text] [Related]
4. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells. Rosenberg AS; Katz SI; Singer A J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443 [TBL] [Abstract][Full Text] [Related]
5. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777 [TBL] [Abstract][Full Text] [Related]
6. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. Yoshimura A; Shiku H; Nakayama E J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592 [TBL] [Abstract][Full Text] [Related]
7. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
8. Development of the immune system in severe combined immunodeficiency mice reconstituted with transferred fetal liver cells. Wakabayashi A; Eishi Y; Nakamura K J Med Dent Sci; 1997 Mar; 44(1):21-9. PubMed ID: 9385039 [TBL] [Abstract][Full Text] [Related]
9. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. Chen PW; Ananthaswamy HN J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126 [TBL] [Abstract][Full Text] [Related]
10. Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity. Cavanagh LL; Halliday GM Cancer Res; 1996 Jun; 56(11):2607-15. PubMed ID: 8653705 [TBL] [Abstract][Full Text] [Related]
11. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts. den Boer AT; van Mierlo GJ; Fransen MF; Melief CJ; Offringa R; Toes RE Cancer Res; 2005 Aug; 65(15):6984-9. PubMed ID: 16061684 [TBL] [Abstract][Full Text] [Related]
12. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection. Haskova Z; Sproule TJ; Roopenian DC; Ksander AB Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232 [TBL] [Abstract][Full Text] [Related]
13. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
14. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791 [TBL] [Abstract][Full Text] [Related]
15. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993 [TBL] [Abstract][Full Text] [Related]
16. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Marzo AL; Lake RA; Robinson BW; Scott B Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965 [TBL] [Abstract][Full Text] [Related]
17. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [TBL] [Abstract][Full Text] [Related]
18. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565 [TBL] [Abstract][Full Text] [Related]
19. CD4+ T cells are both necessary and sufficient for islet xenograft rejection. Gill RG; Wolf L; Daniel D; Coulombe M Transplant Proc; 1994 Jun; 26(3):1203. PubMed ID: 7913259 [No Abstract] [Full Text] [Related]
20. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice. Rosenberg AS Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953 [No Abstract] [Full Text] [Related] [Next] [New Search]